Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
Transl Lung Cancer Res
.
2020 Feb;9(1):1-3.
doi: 10.21037/tlcr.2020.01.05.
Authors
Jacques De Greve
1
,
Philippe Giron
1
Affiliation
1
Laboratory of Medical and Molecular Oncology, Vrije Universiteit Brussel, Brussels, Belgium.
PMID:
32206546
PMCID:
PMC7082287
DOI:
10.21037/tlcr.2020.01.05
No abstract available
Publication types
Editorial
Comment